Columbia Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.69M | Sell |
34,525
-804
| -2% | -$173K | 1.51% | 17 |
|
|
2026
Q1 | $7.68M | Sell |
35,329
-155
| -0.4% | -$34.4K | 1.46% | 16 |
|
|
2025
Q4 | $8.11M | Sell |
35,484
-220
| -0.6% | -$50.1K | 1.44% | 17 |
|
|
2025
Q3 | $8.27M | Sell |
35,704
-774
| -2% | -$158K | 1.55% | 14 |
|
|
2025
Q2 | $6.77M | Sell |
36,478
-874
| -2% | -$162K | 1.33% | 15 |
|
|
2025
Q1 | $7.83M | Sell |
37,352
-1,304
| -3% | -$254K | 1.53% | 14 |
|
|
2024
Q4 | $6.87M | Sell |
38,656
-2,122
| -5% | -$390K | 1.26% | 16 |
|
|
2024
Q3 | $8.05M | Buy |
40,778
+241
| +0.6% | +$45K | 1.4% | 17 |
|
|
2024
Q2 | $6.95M | Buy |
40,537
+172
| +0.4% | +$28.5K | 1.3% | 20 |
|
|
2024
Q1 | $6.25M | Hold |
40,365
| – | – | 1.27% | 18 |
|
|
2023
Q4 | $6.25M | Sell |
40,365
-71
| -0.2% | -$10.4K | 1.27% | 18 |
|
|
2023
Q3 | $6.03M | Sell |
40,436
-366
| -0.9% | -$53.7K | 1.33% | 18 |
|
|
2023
Q2 | $5.5M | Sell |
40,802
-5,484
| -12% | -$804K | 1.17% | 23 |
|
|
2023
Q1 | $7.38M | Sell |
46,286
-864
| -2% | -$132K | 1.66% | 12 |
|
|
2022
Q4 | $7.62M | Sell |
47,150
-265
| -0.6% | -$40.6K | 1.85% | 12 |
|
|
2022
Q3 | $6.36M | Sell |
47,415
-1,243
| -3% | -$178K | 1.67% | 12 |
|
|
2022
Q2 | $7.45M | Buy |
+48,658
| New | +$7.44M | 1.89% | 11 |
|
|
2021
Q4 | $7.53M | Buy |
55,613
+445
| +0.8% | +$52.6K | 1.53% | 15 |
|
|
2021
Q3 | $5.95M | Buy |
55,168
+781
| +1% | +$89.2K | 1.3% | 17 |
|
|
2021
Q2 | $6.13M | Sell |
54,387
-7,740
| -12% | -$872K | 1.36% | 17 |
|
|
2021
Q1 | $6.72M | Buy |
62,127
+5,867
| +10% | +$628K | 1.22% | 23 |
|
|
2020
Q4 | $6.03M | Buy |
56,260
+1,155
| +2% | +$111K | 1.21% | 25 |
|
|
2020
Q3 | $4.83M | Sell |
55,105
-1,129
| -2% | -$106K | 1.11% | 31 |
|
|
2020
Q2 | $5.52M | Sell |
56,234
-44,655
| -44% | -$3.93M | 1.32% | 23 |
|
|
2020
Q1 | $47.7M | Buy |
100,889
+51,440
| +104% | +$4.38M | 11.77% | 1 |
|
|
2019
Q4 | $43.8K | Buy |
49,449
+2,402
| +5% | +$199K | 1.06% | 31 |
|
|
2019
Q3 | $3.56M | Buy |
47,047
+3,440
| +8% | +$236K | 0.93% | 37 |
|
|
2019
Q2 | $3.17M | Buy |
43,607
+7,191
| +20% | +$565K | 0.83% | 39 |
|
|
2019
Q1 | $2.94M | Buy |
36,416
+1,807
| +5% | +$148K | 0.78% | 40 |
|
|
2018
Q4 | $3.19M | Buy |
34,609
+1,365
| +4% | +$120K | 0.97% | 32 |
|
|
2018
Q3 | $3.14M | Buy |
33,244
+571
| +2% | +$54.1K | 0.82% | 41 |
|
|
2018
Q2 | $3.03M | Buy |
32,673
+2,983
| +10% | +$291K | 0.88% | 40 |
|
|
2018
Q1 | $2.81M | Sell |
29,690
-205
| -0.7% | -$22.5K | 0.82% | 43 |
|
|
2017
Q4 | $2.89M | Sell |
29,895
-525
| -2% | -$49.5K | 0.83% | 41 |
|
|
2017
Q3 | $2.7M | Buy |
30,420
+431
| +1% | +$32.8K | 0.83% | 40 |
|
|
2017
Q2 | $2.17M | Buy |
29,989
+100
| +0.3% | +$6.72K | 0.7% | 43 |
|
|
2017
Q1 | $1.95M | Buy |
29,889
+300
| +1% | +$18.9K | 0.65% | 48 |
|
|
2016
Q4 | $1.85M | Buy |
29,589
+1,029
| +4% | +$62.8K | 0.63% | 48 |
|
|
2016
Q3 | $1.8M | Buy |
28,560
+1,062
| +4% | +$68.8K | 0.63% | 48 |
|
|
2016
Q2 | $1.7M | Buy |
27,498
+5
| +0% | +$305 | 0.61% | 48 |
|
|
2016
Q1 | $1.57M | Buy |
27,493
+1,110
| +4% | +$61.9K | 0.58% | 49 |
|
|
2015
Q4 | $1.56M | Buy |
26,383
+35
| +0.1% | +$2.02K | 0.63% | 46 |
|
|
2015
Q3 | $1.43M | Sell |
26,348
-475
| -2% | -$30.9K | 0.58% | 51 |
|
|
2015
Q2 | $1.8M | Buy |
26,823
+200
| +0.8% | +$13.1K | 0.69% | 43 |
|
|
2015
Q1 | $1.56M | Hold |
26,623
| – | – | 0.59% | 51 |
|
|
2014
Q4 | $1.74M | Sell |
26,623
-155
| -0.6% | -$9.77K | 0.67% | 45 |
|
|
2014
Q3 | $1.55M | Sell |
26,778
-200
| -0.7% | -$11.1K | 0.62% | 49 |
|
|
2014
Q2 | $1.52M | Hold |
26,978
| – | – | 0.62% | 51 |
|
|
2014
Q1 | $1.39M | Hold |
26,978
| – | – | 0.6% | 54 |
|
|
2013
Q4 | $1.43M | Buy |
+26,978
| New | +$1.33M | 0.63% | 49 |
|
Other funds holding ABBV
ECSS
ATO
Columbia Asset Management's ABBV Position: Q2 2026 in Review
Columbia Asset Management reduced its AbbVie (ABBV) stake by 2.3% in Q2 2026, selling an estimated $173K and leaving 34,525 shares worth $8.69M. The position accounts for 1.51% of the portfolio, ranked #17.
Columbia Asset Management first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. The position peaked at $47.7M in Q1 2020. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Columbia Asset Management held 34,525 shares of AbbVie worth $8.69M as of Q2 2026.
- Columbia Asset Management sold 804 AbbVie shares in Q2 2026, an estimated $173K.
- AbbVie made up 1.51% of Columbia Asset Management's portfolio in Q2 2026, its #17 holding.
- Columbia Asset Management first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
- Columbia Asset Management's AbbVie position peaked at $47.7M in Q1 2020.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Columbia Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.